The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical Trial.

Linjawi, Sultan; W Bode, Bruce; B Chaykin, Louis; Courrèges, Jean-Pierre; Handelsman, Yehuda; M Lehmann, Lucine; Mishra, Abhishek; W Simpson, Richard

doi:10.1007/s13300-016-0218-3

Public

The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical Trial.

Shared by NobleBlocks on Feb 1, 2017 • 12:00 AM UTC

Authors:

Sultan Linjawi

Bruce W Bode

Louis B Chaykin

Abstract

INTRODUCTION: The progressive nature of type 2 diabetes necessitates treatment intensification. This often involves intensification with oral antidiabetic drugs (OADs) initially, followed by other agents, such as glucagon-like peptide-1 receptor agonists (GLP-1RAs), with the majority of patients eve...

Subject

Clinical trial

GLP-1 receptor agonist

IDegLira

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!